|The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia|
JD McConnell, CG Roehrborn, OM Bautista, GL Andriole Jr, CM Dixon, ...
New England Journal of Medicine 349 (25), 2387-2398, 2003
|Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial|
WJ Catalona, AW Partin, KM Slawin, MK Brawer, RC Flanigan, A Patel, ...
Jama 279 (19), 1542-1547, 1998
|Abstinence and safer sex HIV risk-reduction interventions for African American adolescents: a randomized controlled trial|
JB Jemmott III, LS Jemmott, GT Fong
Jama 279 (19), 1529-1536, 1998
|Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy|
AJ Stephenson, PT Scardino, MW Kattan, TM Pisansky, KM Slawin, ...
Journal of clinical oncology: official journal of the American Society of …, 2007
|Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy|
AJ Stephenson, SF Shariat, MJ Zelefsky, MW Kattan, EB Butler, BS Teh, ...
Jama 291 (11), 1325-1332, 2004
|Do margins matter? The prognostic significance of positive surgical margins in radical prostatectomy specimens|
P Swindle, JA Eastham, M Ohori, MW Kattan, T Wheeler, N Maru, ...
The Journal of urology 174 (3), 903-907, 2005
|A multicenter study of [-2] pro-prostate specific antigen combined with prostate specific antigen and free prostate specific antigen for prostate cancer detection in the 2.0 to …|
WJ Catalona, AW Partin, MG Sanda, JT Wei, GG Klee, CH Bangma, ...
The Journal of urology 185 (5), 1650-1655, 2011
|Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and staging|
WJ Catalona, PC Southwick, KM Slawin, AW Partin, MK Brawer, ...
Urology 56 (2), 255-260, 2000
|Counseling men with prostate cancer: a nomogram for predicting the presence of small, moderately differentiated, confined tumors|
MW Kattan, JA Eastham, TM Wheeler, N Maru, PT Scardino, ...
The Journal of urology 170 (5), 1792-1797, 2003
|Optimal combinations of systematic sextant and laterally directed biopsies for the detection of prostate cancer|
JL Gore, SF Shariat, BJ Miles, D Kadmon, N Jiang, TM Wheeler, ...
The Journal of urology 165 (5), 1554-1559, 2001
|Predicting the presence and side of extracapsular extension: a nomogram for staging prostate cancer|
M Ohori, MW Kattan, H Koh, N Maru, KM Slawin, S Shariat, M Muramoto, ...
The Journal of urology 171 (5), 1844-1849, 2004
|Survivin expression is associated with features of biologically aggressive prostate carcinoma|
SF Shariat, Y Lotan, H Saboorian, SM Khoddami, CG Roehrborn, ...
Cancer 100 (4), 751-757, 2004
|Plasma levels of interleukin-6 and its soluble receptor are associated with prostate cancer progression and metastasis|
SF Shariat, B Andrews, MW Kattan, JH Kim, TM Wheeler, KM Slawin
Urology 58 (6), 1008-1015, 2001
|Association of the circulating levels of the urokinase system of plasminogen activation with the presence of prostate cancer and invasion, progression, and metastasis|
SF Shariat, CG Roehrborn, JD McConnell, S Park, N Alam, TM Wheeler, ...
Journal of Clinical Oncology 25 (4), 349-355, 2007
|Baseline factors as predictors of clinical progression of benign prostatic hyperplasia in men treated with placebo|
ED Crawford, SS Wilson, JD McConnell, KM Slawin, MC Lieber, JA Smith, ...
The Journal of urology 175 (4), 1422-1427, 2006
|A precursor form of prostate-specific antigen is more highly elevated in prostate cancer compared with benign transition zone prostate tissue|
SD Mikolajczyk, LS Millar, TJ Wang, HG Rittenhouse, LS Marks, W Song, ...
Cancer research 60 (3), 756-759, 2000
|The addition of interleukin-6 soluble receptor and transforming growth factor beta1 improves a preoperative nomogram for predicting biochemical progression in patients with …|
MW Kattan, SF Shariat, B Andrews, K Zhu, E Canto, K Matsumoto, ...
Journal of Clinical Oncology 21 (19), 3573-3579, 2003
|“BPSA,” a specific molecular form of free prostate-specific antigen, is found predominantly in the transition zone of patients with nodular benign prostatic hyperplasia|
SD Mikolajczyk, LS Millar, TJ Wang, HG Rittenhouse, RL Wolfert, ...
Urology 55 (1), 41-45, 2000
|Preoperative plasma levels of transforming growth factor beta1 (TGF-β1) strongly predict progression in patients undergoing radical prostatectomy|
SF Shariat, M Shalev, A Menesses-Diaz, IY Kim, MW Kattan, TM Wheeler, ...
Journal of Clinical Oncology 19 (11), 2856-2864, 2001
|Prediction of response to salvage radiation therapy in patients with prostate cancer recurrence after radical prostatectomy|
AK Leventis, SF Shariat, MW Kattan, EB Butler, TM Wheeler, KM Slawin
Journal of clinical oncology 19 (4), 1030-1039, 2001